Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Japan Superconductor Technology (JASTEC) is a Japanese manufacturer of superconducting wires and superconducting magnets, with products used in NMR, MRI, research, and industrial applications. The company develops and supplies NbTi and Nb3Sn superconducting wire, cryogen-free magnets, high-field NMR magnets, and MRI-related superconducting systems. Although its products serve healthcare and pharmaceutical research through MRI and NMR instrumentation, JASTEC is not a drug developer or healthcare company; it is an enabling hardware and materials supplier. JASTEC was founded in 2002 and was acquired by JEOL in January 2025 after previously being a Kobe Steel group company. Its business is centered on commercial manufacturing and sale of superconducting components and magnet systems rather than therapeutics or clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japan Superconductor Technology.